Pandion Therapeutics Inc (PAND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PAND | AMGN | BMY | VRTX | GILD |
| Company | Pandion Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 59.95 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 60.05 | 288.83 | 58.22 | 455.43 | 89.07 |
| Low | 59.95 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 60.05 | 288.32 | 57.86 | 447.49 | 88.84 |
| Change | +0.13 | +0.45 | -0.02 | -3.74 | +0.21 |
| % Change | +0.22% | +0.16% | -0.03% | -0.83% | +0.24% |
| Volume | 241,500 | 505,589 | 1,478,543 | 234,136 | 723,733 |
| 20-Day Average Volume | 267,345 | 2,765,835 | 12,088,836 | 1,279,884 | 7,356,066 |
| Previous Close | 59.92 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 60.07 | 307.19 | 55.90 | 479.04 | 90.82 |
| 20-Day Raw Stochastic | 19.40% | 18.69% | 64.13% | 1.83% | 17.39% |
| 20-Day Relative Strength | 86.37% | 33.79% | 59.50% | 39.85% | 50.26% |
| Weighted Alpha | +75.62 | -0.25 | +24.64 | +16.63 | +23.26 |
| Today's Opinion | N/A | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | N/A | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | N/A | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/24/21 | -3.55% since 11/14/24 | -1.27% since 11/14/24 | -7.74% since 11/14/24 | -4.13% since 11/14/24 |
| Low | 59.92 on 03/30/21 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 60.14 on 03/25/21 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -0.25% since 02/26/21 | -9.89% since 10/21/24 | +10.81% since 10/21/24 | -6.61% since 10/21/24 | +2.34% since 10/21/24 |
| Low | 59.60 on 03/04/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 62.90 on 03/02/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +297.42% since 12/28/20 | -13.29% since 08/21/24 | +19.23% since 08/21/24 | -8.15% since 08/21/24 | +17.54% since 08/21/24 |
| Low | 14.55 on 12/31/20 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 62.90 on 03/02/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +390.60% since 09/28/20 | -9.35% since 05/21/24 | +36.63% since 05/21/24 | +1.02% since 05/21/24 | +31.24% since 05/21/24 |
| Low | 10.28 on 10/28/20 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 62.90 on 03/02/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,772,436 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 29,516 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 8,780,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -38,110,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 2,630,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -11,900,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 04/05/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |